Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (557)

  • Alonso-Dominguez, JM; Casado, LF; Anguita, E; Gomez-Casares, MT; Buno, I; Ferrer-Marin, F; Arenas, A; Del Orbe, R; Ayala, R; Llamas, P; Salgado, RN; Osorio, S; Sanchez-Godoy, P; Burgaleta, C; Mahillo-Fernandez, I; Garcia-Gutierrez, V; Steegmann, JL; Martinez-Lopez, J.

    PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

    PLoS One. 2017; 12(7): Nº de citas: 5 [doi:10.1371/journal.pone.0181366]

  • Negredo, A; de la Calle-Prieto, F; Palencia-Herrejon, E; Mora-Rillo, M; Astray-Mochales, J; Sanchez-Seco, MP; Lopez, EB; Menarguez, J; Fernandez-Cruz, A; Sanchez-Artola, B; Keough-Delgado, E; de Arellano, ER; Lasala, F; Milla, J; Fraile, JL; Gavin, MO; de la Gandara, AM; Perez, LL; Diaz-Diaz, D; Lopez-Garcia, MA; Delgado-Jimenez, P; Martin-Quiros, A; Trigo, E; Figueira, JC; Manzanares, J; Rodriguez-Baena, E; Garcia-Comas, L; Rodriguez-Fraga, O; Garcia-Arenzana, N; Fernandez-Diaz, MV; Cornejo, VM; Emmerich, P; Schmidt-Chanasit, J; Arribas, JR; Crimean Congo Hemorrhagic Fever.

    Autochthonous Crimean-Congo Hemorrhagic Fever in Spain

    NEW ENGLAND JOURNAL OF MEDICINE. 2017; 377(2): 154-161 Nº de citas: 165 [doi:10.1056/NEJMoa1615162]

  • Garrido-Colino, C; Lassaletta, A; Vazquez, MA; Echevarria, A; Gutierrez, I; Andion, M; Berlanga, P; Comite Adolescentes SEHOP.

    Current situation on fertility preservation in cancer patients in Spain: Level of knowledge, information, and professional involvement

    ANALES DE PEDIATRIA. 2017; 87(1): 3-8 Nº de citas: 5 [doi:10.1016/j.anpedi.2016.04.019]

  • Cela, E; Bellon, JM; de la Cruz, M; Belendez, C; Berrueco, R; Ruiz, A; Elorza, I; de Heredia, CD; Cervera, A; Valles, G; Salinas, JA; Coll, MT; Bermudez, M; Prudencio, M; Argiles, B; Vecilla, C; SEHOP.

    National registry of hemoglobinopathies in Spain (REPHem)

    PEDIATRIC BLOOD & CANCER. 2017; 64(7): Nº de citas: 35 [doi:10.1002/pbc.26322]

  • Lopez, LV; de la Rosa, TV; de la Camara, R; Espigado, I; Cerrato, SG; Jurado, M; Rovira, M; Salavert, M; Simonneau, DS; Vercet, CS; Camps, IR.

    Consensus opinion on antifungal prophylaxis in haematologic patients: Results of the PROMIC project

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2017; 30(3): 213-223 Nº de citas: 2

  • Sanz, J; Kwon, M; Bautista, G; Sanz, MA; Balsalobre, P; Pinana, JL; Solano, C; Duarte, R; Ferra, C; Lorenzo, I; Martin, C; Barba, P; Pascual, MJ; Martino, R; Gayoso, J; Buno, I; Regidor, C; de la Iglesia, A; Montoro, J; Diez-Martin, JL; Sanz, GF; Cabrera, R; Grp Espanol Trasplante.

    Single umbilical cord blood with or without CD34(+) cells from a third-party donor in adults with leukemia

    Blood Advances. 2017; 1(15): 1047-1055 Nº de citas: 9 [doi:10.1182/bloodadvances.2017006999]

  • Sobrino-Fernandez, E; Campos-Dominguez, M; Gregorio-Hernandez, R; Huerta-Aragones, J; Belendez-Bieler, C; Lancharro-Zapata, A; Franco-Fernandez, ML; Bernardo-Atienza, B; Sanchez-Luna, M.

    Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis

    PEDIATRIC DERMATOLOGY. 2017; 34(3): 128-129 Nº de citas: 5 [doi:10.1111/pde.13101]

  • Cayrol, J; Colino, CG.

    Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2017; 39(4): 187-190 Nº de citas: 6 [doi:10.1097/MPH.0000000000000785]

  • Vazquez, L; Salavert, M; Gayoso, J; Lizasoain, M; Camps, IR; Di Benedetto, N; Study Grp Risk Factors IFI Using.

    Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2017; 30(2): 103-117 Nº de citas: 6

  • Bardon-Cancho, EJ; Haro-Diaz, A; Alonso-Garcia-de la Rosa, F; Huerta-Aragones, J; Garcia-Morin, M; Gonzalez-Martinez, F; Garrido-Colino, C.

    DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations

    FAMILIAL CANCER. 2017; 16(2): 291-294 Nº de citas: 9 [doi:10.1007/s10689-016-9949-6]

  • Garcia-Montoya, L; Saenz-Tenorio, CN; Janta, I; Menarguez, J; Lopez-Longo, FJ; Monteagudo, I; Naredo, E.

    Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review

    RHEUMATOLOGY INTERNATIONAL. 2017; 37(4): 663-669 Nº de citas: 11 [doi:10.1007/s00296-016-3601-5]

  • Garcia-Gutierrez, V; Gomez-Casares, MT; Puerta, JM; Alonso-Dominguez, JM; Osorio, S; Hernandez-Boiuda, JC; Collado, R; Ramirez, MJ; Ibanez, F; Martin, ML; Rodriguez-Gambarte, JD; Martinez-Laperche, C; Gomez, M; Fiallo, DV; Redondo, S; Rodriguez, A; Ruiz-Nuno, C; Steegmann, JL; Jimenez-Velasco, A.

    A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

    PLoS One. 2017; 12(3): Nº de citas: 6 [doi:10.1371/journal.pone.0173532]

  • Morin, MG; Cela, E; Garrido, C; Cancho, EB; del Hoyo, AA; Pascual, C; Perez-Corral, A; Belendez, C.

    Bone marrow transplant in patients with sickle cell anaemia. Experience in one centre

    ANALES DE PEDIATRIA. 2017; 86(3): 142-150 Nº de citas: 8 [doi:10.1016/j.anpedi.2016.03.014]

  • Montalban, C; Diaz-Lopez, A; Dlouhy, I; Rovira, J; Lopez-Guillmermo, A; Alonso, S; Martin, A; Sancho, JM; Garcia, O; Sanchez, JM; Rodriguez, M; Novelli, S; Salar, A; Gutierrez, A; Rodriguez-Salazar, MJ; Bastos, M; Dominguez, JF; Fernandez, R; de Villambrosia, SG; Queizan, JEA; Cordoba, R; de Ona, R; Lopez-Hernandez, A; Freue, JM; Garrote, H; Lopez, L; Martin-Moreno, AM; Rodriguez, J; Abraira, V; Garcia, JF.

    Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of beta(2)-microglobulin yields a more accurate GELTAMO-IPI

    BRITISH JOURNAL OF HAEMATOLOGY. 2017; 176(6): 918-928 Nº de citas: 77 [doi:10.1111/bjh.14489]

  • Ruggeri, A; Sun, YQ; Labopin, M; Bacigalupo, A; Lorentino, F; Arcese, W; Santarone, S; Gulbas, Z; Blaise, D; Messina, G; Ghavamzadeh, A; Malard, F; Bruno, B; Diez-Martin, JL; Koc, Y; Ciceri, F; Mohty, M; Nagler, A.

    Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant

    HAEMATOLOGICA. 2017; 102(2): 401-410 Nº de citas: 119 [doi:10.3324/haematol.2016.151779]

  • Reina-Castillon, J; Pujol, R; Lopez-Sanchez, M; Rodriguez-Santiago, B; Aza-Carmona, M; Gonzalez, JR; Casado, JA; Bueren, JA; Sevilla, J; Badel, I; Catala, A; Belendez, C; Dasi, MA; de Heredia, CD; Soulier, J; Schindler, D; Perez-Jurado, LA; Surralles, J.

    Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia

    Blood Advances. 2017; 1(5): 319-329 Nº de citas: 18 [doi:10.1182/bloodadvances.2016000943]

  • Rubio, MT; D'Aveni-Piney, M; Labopin, M; Hamladji, RM; Sanz, MA; Blaise, D; Ozdogu, H; Daguindeau, E; Richard, C; Santarone, S; Irrera, G; Yakoub-Agha, I; Yeshurun, M; Diez-Martin, JL; Mohty, M; Savani, BN; Nagler, A.

    Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

    JOURNAL OF HEMATOLOGY & ONCOLOGY. 2017; 10: Nº de citas: 28 [doi:10.1186/s13045-016-0389-4]

  • Cervantes, F; Correa, JG; Perez, I; Garcia-Gutierrez, V; Redondo, S; Colomer, D; Jimenez-Velasco, A; Steegmann, JL; Sanchez-Guijo, F; Ferrer-Marin, F; Pereira, A; Osorio, S.

    Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response

    ANNALS OF HEMATOLOGY. 2017; 96(1): 81-85 Nº de citas: 25 [doi:10.1007/s00277-016-2839-z]